Race Oncology (ASX:RAC) Activates First Australian Clinical Site for RC220 Trial
Race Oncology (ASX:RAC) initiates its first Australian clinical site for the Phase 1 RC220 trial, marking a significant step in advancing cancer treatment.
Race Oncology (ASX:RAC) initiates its first Australian clinical site for the Phase 1 RC220 trial, marking a significant step in advancing cancer treatment.
Bioxyne Limited (ASX:BXN) secures a $7 million manufacturing agreement with NectarTek, significantly increasing FY2026 revenue projections.
Biome Australia Limited (ASX:BIO) secures a $5.0 million debt facility with NAB to drive growth and enhance financial stability.
Synlait Milk Limited (ASX: SM1) secures future milk supply with majority of cease notices withdrawn, ensuring adequate volumes for FY26 and FY27.
Cettire Limited (ASX:CTT) assesses the impact of new US tariffs on EU goods, affecting 41% of H1-FY25 sales.
Pure Hydrogen Corporation Limited (ASX:PH2) secures a $44 million agreement with GreenH2 LATAM to supply hydrogen infrastructure for Mexican projects.
St George Mining Limited (ASX:SGQ) completes acquisition of the Araxá Project, a world-class niobium and rare earths venture in Brazil.
Livium Ltd (ASX:LIT) receives a A$850k grant from the WA Government to develop a battery recycling facility, enhancing their national e-waste strategy.
Turaco Gold (ASX:TCG) confirms significant shallow gold mineralisation at Begnopan, enhancing future resource growth prospects at the Afema Project.
Tesoro Gold (ASX:TSO) announces two new high-potential drill targets near the Ternera Deposit, expanding the El Zorro Gold Project.